Iconic Therapeutics

Drug development ophthalmology


HBM contact: Dr Matthias Fehr

Company status: private

Iconic Therapeutics is a clinical-stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines for serious diseases. The company’s expertise in the role of Tissue Factor (TF) in angiogenesis, inflammation, and metastasis has allowed us to develop a unique therapeutic approach to retinal disease and cancer. 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171